TVRD · Tvardi Therapeutics Inc
United States · RS rating 5 · As of 2026-11-03
| Price | 0.83 USD |
|---|---|
| 1-day change | +3.7% |
| RS rating (overall / 1M / 3M / 12M) | 5 / 15 / 6 / 8 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 10 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -32.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +83.3% |
| Market cap (USD) | $28.2M |